Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ravenquest Biomed Inc RVVQF

Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Comment by McMoney2on Jan 16, 2020 4:17pm
74 Views
Post# 30562062

RE:RE:If George had something to say...

RE:RE:If George had something to say...I would think that at this stage, anyone buying RQB would buy assets not shares to avoid litigation risks. As far as value is concerned, we are only worth what someone is willing to pay which the moment is very little. It's strange to me that since announcing the purchase of Digigro that no one has been able to give any real insight into this company itself or a reasonable explaination for the pivot to the tech side of the business.
Currently this SP tells me that; 1) we aren't able to grow as sell. period. If we were, they would have been touting in on their twitter feed. 2) there is actually nothing lined up for the debentures yet. 3) the patent litigation has a stronger case than they are letting on. 4) the counter suite was to just to buy time while playing chicken. 5) the JV walked  6) we are in an identity Crisis. 

If im right, then we deserve this SP. And that is a hard pill to swallow as a shareholder. 


<< Previous
Bullboard Posts
Next >>